$GWTI
Greenway Technologies Inc Stock $gwti

$gwti Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000149315223029460 Filed on August 18, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$180.0K	$210.0K	$247.7K
YoY Change	-22.02%	-15.23%	-10.8%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$181.9K	$207.6K	$247.7K
YoY Change	-21.19%	-16.21%	-23.95%
Operating Profit	-$181.9K	-$207.6K	-$247.7K
YoY Change	-21.19%	-16.21%	-23.95%
Interest Expense	-$160.0K	-$150.0K	$174.4K
YoY Change	-186.46%	-186.0%	17.93%
% of Operating Profit
Other Income/Expense, Net	-$156.2K	-$154.6K	-$104.0K
YoY Change	-15.61%	48.56%	-29.65%
Pretax Income	-$340.0K	-$360.0K	-$351.8K
YoY Change	-18.25%	2.34%	-25.73%
Income Tax
% Of Pretax Income
Net Earnings	-$338.1K	-$362.1K	-$351.8K
YoY Change	-18.71%	2.95%	-25.73%
Net Earnings / Revenue
Basic Earnings Per Share	$0.00	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00	-$949.30
COMMON SHARES
Basic Shares Outstanding	400.7M shares	392.9M shares	370.6M shares
Diluted Shares Outstanding	401.6M shares	396.8M shares	370.6M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$0.00	$7.020K	$35.19K
YoY Change	-100.0%	-80.05%	-37.3%
Cash & Equivalents	$1.290K	$7.016K	$35.19K
Short-Term Investments
Other Short-Term Assets	$0.00	$0.00	$4.590K
YoY Change	-100.0%	-100.0%	4490.0%
Inventory
Prepaid Expenses			$4.592K
Receivables
Other Receivables
Total Short-Term Assets	$1.290K	$7.016K	$39.79K
YoY Change	-96.97%	-82.37%	-29.23%
LONG-TERM ASSETS
Property, Plant & Equipment			$0.00
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$0.00	$0.00	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$1.290K	$7.016K	$39.79K
Total Long-Term Assets	$0.00	$0.00	$0.00
Total Assets	$1.290K	$7.016K	$39.79K
YoY Change	-96.97%	-82.37%	-29.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.010M	$7.704M	$575.2K
YoY Change	16.26%	1239.38%	-20.51%
Accrued Expenses			$1.131M
YoY Change			-78.09%
Deferred Revenue
YoY Change
Short-Term Debt	$650.0K	$652.5K	$0.00
YoY Change	-5.45%
Long-Term Debt Due	$2.970M	$2.972M	$3.666M
YoY Change	0.16%	-18.92%	19.1%
Total Short-Term Liabilities	$11.63M	$11.33M	$10.33M
YoY Change	10.32%	9.74%	13.96%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change			-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.63M	$11.33M	$10.33M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$11.63M	$11.33M	$10.33M
YoY Change	10.28%	9.74%	7.72%
SHAREHOLDERS EQUITY
Retained Earnings	-$37.46M	-$37.12M	-$35.52M
YoY Change	4.25%	4.52%
Common Stock	$25.83M	$25.80M	$25.38M
YoY Change	1.56%	1.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$11.63M	-$11.33M	-$10.29M
YoY Change
Total Liabilities & Shareholders Equity	$1.290K	$7.016K	$39.79K
YoY Change	-96.97%	-82.37%	-29.23%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	-$338.1K	-$362.1K	-$351.8K
YoY Change	-18.71%	2.95%	-25.73%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$30.00K	-$90.78K	-$108.3K
YoY Change	-82.69%	-16.16%	-60.83%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	30.00K	97.80K	143.0K
YoY Change	-82.63%	-31.61%	-56.96%
NET CHANGE
Cash From Operating Activities	-30.00K	-90.78K	-108.3K
Cash From Investing Activities
Cash From Financing Activities	30.00K	97.80K	143.0K
Net Change In Cash	-0.00000000001819	7.020K	34.72K
YoY Change	-100.0%	-79.78%	-37.77%
FREE CASH FLOW
Cash From Operating Activities	-$30.00K	-$90.78K	-$108.3K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	GWTI	Common Stock To Be Issued CommonStockToBeIssued		usd
CY2023Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001572386
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q2	GWTI	Stock Issued During Period Value For Promissory Note Fees StockIssuedDuringPeriodValueForPromissoryNoteFees		usd
	GWTI	Stock Issued During Period Value Issuance Of Previously Issuable Shares StockIssuedDuringPeriodValueIssuanceOfPreviouslyIssuableShares		usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1		usd
	GWTI	Stocks And Warrants Issued During Period Value Preferred Stock And Warrants StocksAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants		usd
	GWTI	Reduction Of Advances In Exchange For Payment Of Warrants ReductionOfAdvancesInExchangeForPaymentOfWarrants		usd
	GWTI	Shares Issued For Promissory Note Fees SharesIssuedForPromissoryNoteFees		usd
	GWTI	Subscription Receivable For Shares Issued For Private Placement SubscriptionReceivableForSharesIssuedForPrivatePlacement		usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-55030
	dei	Entity Registrant Name EntityRegistrantName	GREENWAY TECHNOLOGIES, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	TX
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-0893594
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1521 North Cooper Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 205
	dei	Entity Address City Or Town EntityAddressCityOrTown	Arlington
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	76011
	dei	City Area Code CityAreaCode	(561)
	dei	Local Phone Number LocalPhoneNumber	809-4644
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	400744204	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7016	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24595	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2947	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	7016	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	27542	usd
CY2023Q2	us-gaap	Assets Assets	7016	usd
CY2022Q4	us-gaap	Assets Assets	27542	usd
CY2023Q2	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	652500	usd
CY2022Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	672500	usd
CY2023Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	166667	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	166667	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	11332456	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10765118	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	400744204	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	400744204	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	382610871	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	382610871	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	40075	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	38262	usd
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	25759218	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	25498031	usd
CY2022Q4	GWTI	Common Stock To Be Issued CommonStockToBeIssued	5000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-37124733	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-36278869	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-11325440	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-10737576	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7016	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27542	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	207577	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	247733	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	207577	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	247733	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-207577	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-247733	usd
CY2023Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	154568	usd
CY2022Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	141410	usd
CY2022Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	33009	usd
CY2022Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	70377	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-154568	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-104042	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-362145	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-351775	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	396848233	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	396848233	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	370584246	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	370584246	shares
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	538168	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	485732	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16000	usd
	us-gaap	Operating Expenses OperatingExpenses	538168	usd
	us-gaap	Operating Expenses OperatingExpenses	501732	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-538168	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-501732	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	307696	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	282820	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	70377	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	39201	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-307696	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-251644	usd
	us-gaap	Net Income Loss NetIncomeLoss	-845864	usd
	us-gaap	Net Income Loss NetIncomeLoss	-753376	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	392686009	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	392686009	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	365552744	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	365552744	shares
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-11066295	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	103000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-362145	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-11325440	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-10217985	usd
CY2022Q2	GWTI	Stock Issued During Period Value To Settle Accrued Liabilities StockIssuedDuringPeriodValueToSettleAccruedLiabilities	155000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	128000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-351775	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-10286760	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-10737576	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	238000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	20000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-845864	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-11325440	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-9886820	usd
	GWTI	Stock Issued During Period Value Settlement Of Subscription Receivable StockIssuedDuringPeriodValueSettlementOfSubscriptionReceivable	16245	usd
	GWTI	Stock Issued During Period Shares For Promissory Note Fees StockIssuedDuringPeriodSharesForPromissoryNoteFees	302038	shares
	GWTI	Stock Issued During Period Value For Promissory Note Fees StockIssuedDuringPeriodValueForPromissoryNoteFees	-3009	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	185200	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	155000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-753376	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-10286760	usd
	us-gaap	Net Income Loss NetIncomeLoss	-845864	usd
	us-gaap	Net Income Loss NetIncomeLoss	-753376	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	39201	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	70377	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2947	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4536	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	235968	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-5075	usd
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	371370	usd
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	580107	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-235579	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-214056	usd
	GWTI	Proceeds From Advances Related Parties ProceedsFromAdvancesRelatedParties	200	usd
	GWTI	Proceeds From Advances Related Parties ProceedsFromAdvancesRelatedParties	3500	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	200	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	20000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	25000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	30000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	238000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	180200	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	218000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	188700	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-17579	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-25356	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	24595	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	60549	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7016	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	35193	usd
	us-gaap	Interest Paid Net InterestPaidNet	20379	usd
	us-gaap	Stock Issued1 StockIssued1	1991	usd
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	51769	usd
	GWTI	Stocks And Warrants Issued During Period Value Preferred Stock And Warrants StocksAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	5000	usd
	GWTI	Reduction Of Advances In Exchange For Payment Of Warrants ReductionOfAdvancesInExchangeForPaymentOfWarrants	16245	usd
	GWTI	Shares Issued For Promissory Note Fees SharesIssuedForPromissoryNoteFees	14180	usd
	GWTI	Shares Issued For Settlement Of Liability Related Party SharesIssuedForSettlementOfLiabilityRelatedParty	20000	usd
	GWTI	Shares Issued For Settlement Of Liability Related Party SharesIssuedForSettlementOfLiabilityRelatedParty	155000	usd
	GWTI	Subscription Receivable For Shares Issued For Private Placement SubscriptionReceivableForSharesIssuedForPrivatePlacement	150000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-845864	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-235579	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-37124733	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-11325440	usd
CY2023Q2	GWTI	Working Capital Deficit WorkingCapitalDeficit	11325440	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7016	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84D_eus-gaap--UseOfEstimates_zprQbTb4tUi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_zkLPMBSUik19">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preparing financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates, and those estimates may be material.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes in estimates are recorded in the period in which they become known. The Company bases its estimates on historical experience and other assumptions, which include both quantitative and qualitative assessments that it believes to be reasonable under the circumstances.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant estimates during the six months ended June 30, 2023 and 2022, respectively, include valuation of stock-based compensation, uncertain tax positions, and the valuation allowance on deferred tax assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GREENWAY TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>JUNE 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	0	usd
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	0	usd
CY2019Q4	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	90377	usd
CY2021Q4	us-gaap	Loss Contingency Damages Paid Value LossContingencyDamagesPaidValue	20000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	70377	usd
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3875000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5083333	shares
	us-gaap	Common Stock Voting Rights CommonStockVotingRights	Voting at 1 vote per share
CY2023Q1	us-gaap	Share Price SharePrice	0.02
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_844_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zj9Kb1G80Hnl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_z4dlJ8F7cxm">Reclassifications</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior year amounts have been reclassified for consistency with the current year presentation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company combined various accrued liabilities into one caption called accounts payable and accrued expenses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company combined various accrued liabilities with related parties into one caption called accounts payable and accrued expenses – related parties.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company separately disclosed it notes payable and convertible notes payable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company separately reflected amortization of debt discount from interest expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This reclassification had no effect on the consolidated results of operations, stockholders’ deficit, or cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

Files In Submission

Name	View Source	Status
0001493152-23-029460-index-headers.html	Edgar Link	pending
0001493152-23-029460-index.html	Edgar Link	pending
0001493152-23-029460.txt	Edgar Link	pending
0001493152-23-029460-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
form10q_001.jpg	Edgar Link	pending
gwti-20230630.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
gwti-20230630_cal.xml	Edgar Link	unprocessable
gwti-20230630_def.xml	Edgar Link	unprocessable
gwti-20230630_lab.xml	Edgar Link	unprocessable
gwti-20230630_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GWTI
Greenway Technologies Inc Stock $gwti

2023 Q3 Form 10-Q Financial Statement

#000149315223029460 Filed on August 18, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GWTI Greenway Technologies Inc Stock $gwti

2023 Q3 Form 10-Q Financial Statement

#000149315223029460 Filed on August 18, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GWTI
Greenway Technologies Inc Stock $gwti